Literature DB >> 10696464

New concepts and methods of standardizing predictive value, accuracy and incorrect diagnostic rate.

H Shen1, Q Chen.   

Abstract

OBJECTIVE: To express the value of a diagnostic test under standardized and comparable conditions. STUDY
DESIGN: Four new concepts of standardizing positive predictive value (SPPV), standardizing negative predictive value (SNPV), standardizing accuracy (SAc) and standardizing an incorrect diagnostic test were developed. The theoretical positive predictive value (SPPV), theoretical negative predictive value (SNPV), theoretical accuracy (SAc) and theoretical incorrect diagnosis rate (SIDR), which are not affected by a different constituent ratio of disease and nondisease groups and are obtained under the theoretical standard condition that the sample size in the disease group equals that in the nondisease group, were defined. Based on these concepts and the principles and methods of statistics and evaluation of diagnostic tests, corresponding formulas were deduced.
RESULTS: The formulas are: SPPV = a(b + d)/[a(b + d) + b(a + c)] = Se/(1 + Se - Sp), SNPV = d(a + c)/[c(b + d) + d(a + c)] = Sp/(1 - Se + Sp), SAc = [a(b + d) + d(a + c)]/[2(a + c)(b + d)] = (Se + Sp)/2, and SIDR = [b(a + c) + c(b + d)]/[2(a + c)(b + d)] = (2 - Se - Sp)/2. Here, a, b, c and d refer to the case numbers of true positives, false positives, false negatives and true negatives; Se and Sp refer, respectively, to sensitivity and specificity.
CONCLUSION: SPPV, SNPV, SAc and SIDR are very useful for expressing and evaluating the value of a diagnostic test under standardized and comparable conditions.

Entities:  

Mesh:

Year:  2000        PMID: 10696464

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  1 in total

1.  Serum p53 protein and anti-p53 antibodies are associated with increased cancer risk: a case-control study of 569 patients and 879 healthy controls.

Authors:  Min Wu; Chen Mao; Qing Chen; Xin-Wei Cu; Wei-Seng Zhang
Journal:  Mol Biol Rep       Date:  2009-08-20       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.